Target intelligence / Profile preview

RNA, U2 small nuclear 35, pseudogene (RNU2-35P)

Target
RNU2-35P
Molecular classification
Other, Pseudogene, Non-coding RNA, Small nuclear RNA (snRNA, pseudogene-derived)
01

Overview

RNA, U2 small nuclear 35, pseudogene (RNU2-35P) is a genomic DNA sequence classified as a pseudogene of the U2 small nuclear RNA (snRNA) gene, specifically annotated as the 35th member in this pseudogene family. U2 snRNA genes encode RNA molecules that are core components of the spliceosome and essential for pre-mRNA splicing, but pseudogenes like RNU2-35P do not produce functional RNA transcripts and are not involved in biological processes or disease pathways. There is no evidence to suggest that RNU2-35P has any regulatory or pathological relevance in humans[1]. Notes: - RNU2-35P is frequently catalogued in genomic databases as a pseudogene and not an active gene, enzyme, receptor, or recognized therapeutic target[1]. - While functional U2 snRNA is crucial for mRNA splicing[2][3][4], RNU2-35P does not contribute to this process. - No known drugs or compounds interact with RNU2-35P, nor is it used as a biomarker or target for therapy. Summary: RNU2-35P represents a pseudogene of U2 snRNA, is not a therapeutic target or a functional gene, and has no current implication in biology or medicine[1].

Other names
RNU2-35PRNA, U2 small nuclear 35, pseudogene
02

Mechanism of action

None

03

Biological functions

None (as a pseudogene, RNU2-35P does not encode a functional product)
04

Disease associations

None known (no disease associations or functional involvement as a pseudogene)

Beyond the preview

Go deeper on RNA, U2 small nuclear 35, pseudogene (RNU2-35P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U2 small nuclear 35, pseudogene (RNU2-35P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call